Old Web
English
Sign In
Acemap
>
authorDetail
>
Roshun Rahimi
Roshun Rahimi
University of California, San Francisco
Homologous Recombination Deficiency
phase i study
Irinotecan
Pathology
Rucaparib
2
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.
2020
Nature Communications
Manuela Terranova-Barberio
Nela Pawlowska
Mallika Sachdev Dhawan
Mark M. Moasser
Amy Jo Chien
Michelle E. Melisko
Hope S. Rugo
Roshun Rahimi
Travis Deal
Adil Daud
Michael Rosenblum
Scott Thomas
Pamela N. Munster
Show All
Source
Cite
Save
Citations (30)
Phase I study of rucaparib and irinotecan in advanced solid tumors with homologous recombination deficiency (HRD) mutations.
2020
Journal of Clinical Oncology
Mallika Sachdev Dhawan
Roshun Rahimi
Silpa Karipineni
Lauren Wilch
Erika Zigman
Rahul Aggarwal
Jennifer A. Grabowsky
Pamela N. Munster
Show All
Source
Cite
Save
Citations (1)
1
map